Vitamin D and Cardiovascular Disease.
暂无分享,去创建一个
[1] R. Jorde,et al. Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data. , 2015, JAMA internal medicine.
[2] J. Pankow,et al. Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study. , 2015, JACC. Heart failure.
[3] R. Mensink,et al. Effects of Supplementation with the Fat-Soluble Vitamins E and D on Fasting Flow-Mediated Vasodilation in Adults: A Meta-Analysis of Randomized Controlled Trials , 2015, Nutrients.
[4] F. Harrell,et al. Vitamin D Therapy in Individuals With Prehypertension or Hypertension: The DAYLIGHT Trial , 2015, Circulation.
[5] Ross M. Fraser,et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study , 2014, The lancet. Diabetes & endocrinology.
[6] J. Ioannidis,et al. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials , 2014, BMJ : British Medical Journal.
[7] H. DeLuca. History of the discovery of vitamin D and its active metabolites. , 2014, BoneKEy reports.
[8] Ishir Bhan,et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. , 2013, The New England journal of medicine.
[9] P. Donnan,et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. , 2013, JAMA internal medicine.
[10] S. Kunutsor,et al. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants , 2013, European Journal of Epidemiology.
[11] B. Cheung,et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. , 2013, Atherosclerosis.
[12] J. Manson,et al. Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.
[13] Christine L. Taylor,et al. IOM committee members respond to Endocrine Society vitamin D guideline. , 2012, The Journal of clinical endocrinology and metabolism.
[14] J. Manson,et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. , 2012, Contemporary clinical trials.
[15] Christopher S. Law,et al. Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy , 2011, Circulation.
[16] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[17] S. Larsson,et al. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis , 2011, Journal of hypertension.
[18] B. Horne,et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. , 2010, The American journal of cardiology.
[19] Daniel L. Koller,et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.
[20] A. Morris,et al. The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial , 2010, Diabetologia.
[21] Markku Heliövaara,et al. Vitamin D status and the risk of cardiovascular disease death. , 2009, American journal of epidemiology.
[22] K. Schechtman,et al. 1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.
[23] Carlos A Camargo,et al. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.
[24] Christopher S. Law,et al. Expression of the Vitamin D Receptor Is Increased in the Hypertrophic Heart , 2008, Hypertension.
[25] W. März,et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.
[26] K. Cao,et al. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. , 2008, Kidney international.
[27] E. Rimm,et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.
[28] J. Sugden,et al. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[29] D. Tishkoff,et al. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. , 2008, Endocrinology.
[30] Michael J. Pencina,et al. Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.
[31] C. Mathieu,et al. Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.
[32] K. Zhu,et al. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. , 2008, Archives of internal medicine.
[33] N. Bodyak,et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals , 2007, Proceedings of the National Academy of Sciences.
[34] C. Mathieu,et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. , 2007, Diabetes research and clinical practice.
[35] Edward Giovannucci,et al. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.
[36] D. Tishkoff,et al. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[37] R. Simpson,et al. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[38] J. Manson,et al. Calcium/Vitamin D Supplementation and Cardiovascular Events , 2007, Circulation.
[39] R. Blumenthal,et al. Vitamin D supplementation and cardiovascular disease risk. , 2007, Circulation.
[40] R. Simpson,et al. Calcitriol modulation of cardiac contractile performance via protein kinase C. , 2006, Journal of molecular and cellular cardiology.
[41] Xiaoan Ruan,et al. Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. , 2006, Atherosclerosis.
[42] M. Aldea,et al. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. , 2006, Kidney international.
[43] G. Targher,et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.
[44] E. Warburton,et al. Reduced Vitamin D in Acute Stroke , 2006, Stroke.
[45] M. Mathieu,et al. Clinical and laboratory safety of one year's use of acombination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: Results of a mlticenter, rndomized, double-blind, placebo-controlled study , 2005 .
[46] N. Stern,et al. 25-Hydroxyvitamin D3-1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds , 2005, Circulation.
[47] Yoko Yamamoto,et al. Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice* , 2004, Journal of Biological Chemistry.
[48] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[49] Guilin Qiao,et al. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[50] R. Doll,et al. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.
[51] T. Shinki,et al. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. , 2002, Biochemical and biophysical research communications.
[52] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .
[53] R. Perez-Fernandez,et al. Ontogenesis of the vitamin D receptor in rat heart , 2002, Histochemistry and Cell Biology.
[54] B. Dawson-Hughes,et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.
[55] D. Wheeler,et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.
[56] S. Cummings,et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. , 2001, The Journal of clinical endocrinology and metabolism.
[57] N. Bundred,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Angiogenesis In Vitro and In Vivo , 2000 .
[58] S. Rostand. Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1997, Hypertension.
[59] A. K. Jarvis,et al. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. , 1997, The American journal of physiology.
[60] T. O’Connell,et al. IMMUNOCHEMICAL IDENTIFICATION OF THE 1,25‐DIHYDROXYVITAMIN D3RECEPTOR PROTEIN IN HUMAN HEART , 1996, Cell biology international.
[61] D S Grimes,et al. Sunlight, cholesterol and coronary heart disease. , 1996, QJM : monthly journal of the Association of Physicians.
[62] J. Wu,et al. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. , 1996, The Journal of clinical investigation.
[63] A. Dobson,et al. Seasons, temperature and coronary disease. , 1993, International journal of epidemiology.
[64] T. Onaya,et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. , 1991, Prostaglandins.
[65] T M Allan,et al. Composition of Seasonality of Disease , 1991, Scottish medical journal.
[66] R. Morris,et al. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. , 1991, The Journal of clinical investigation.
[67] R. Beaglehole,et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.
[68] D. Saunders,et al. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. , 1990, The American journal of physiology.
[69] A. Fleck. LATITUDE AND ISCHAEMIC HEART DISEASE , 1989, The Lancet.
[70] R. Simpson,et al. Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. , 1987, The American journal of physiology.
[71] M. Fanger,et al. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. , 1987, The Journal of clinical investigation.
[72] R. Simpson,et al. Vitamin D3 and cardiovascular function in rats. , 1987, The Journal of clinical investigation.
[73] W. Claycomb,et al. 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells. , 1987, The Journal of biological chemistry.
[74] M. Walters,et al. 1,25-Dihydroxyvitamin D3 receptors identified in the rat heart. , 1986, Journal of molecular and cellular cardiology.
[75] R. Simpson,et al. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. , 1985, The Journal of biological chemistry.
[76] A. Voors,et al. Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States. , 1979, Journal of chronic diseases.
[77] B. Macmahon,et al. Reduction in mortality from coronary heart disease in men residing at high altitude. , 1977, The New England journal of medicine.